0000000000485850

AUTHOR

Sandrine Dufort

showing 4 related works from this author

Minor changes in the macrocyclic ligands but major consequences on the efficiency of gold nanoparticles designed for radiosensitization

2016

International audience; Many studies have been devoted to adapting the design of gold nanoparticles to efficiently exploit their promising capability to enhance the effects of radiotherapy. In particular, the addition of magnetic resonance imaging modality constitutes an attractive strategy for enhancing the selectivity of radiotherapy since it allows the determination of the most suited delay between the injection of nanoparticles and irradiation. This requires the functionalization of the gold core by an organic shell composed of thiolated gadolinium chelates. The risk of nephrogenic systemic fibrosis induced by the release of gadolinium ions should encourage the use of macrocyclic chelat…

BiodistributiontumorMaterials scienceGadoliniumchemistry.chemical_elementNanoparticleContext (language use)Nanotechnology02 engineering and technology[CHIM.THER]Chemical Sciences/Medicinal Chemistry010402 general chemistry01 natural sciences[ CHIM ] Chemical Sciencesnephrogenic systemic fibrosis[CHIM]Chemical SciencesGeneral Materials ScienceChelationratbiodistributionradiotherapyrenal clearance[ CHIM.THER ] Chemical Sciences/Medicinal Chemistry021001 nanoscience & nanotechnologyCombinatorial chemistry0104 chemical scienceschemistrymri contrast agentsColloidal goldSurface modification0210 nano-technologySelectivitydihydrolipoic acidmicrobeam radiation-therapy9l gliosarcoma
researchProduct

Ultrasmall Rigid Particles as Multimodal Probes for Medical Applications

2011

International audience; Ultrasmall but multifunctional: Rigid imaging particles that are smaller than 5 nm in size can be obtained in a top-down process starting from a core–shell structure (core=gadolinium oxide; shell=polysiloxane). They represent the first multifunctional silica-based particles that are sufficiently small to escape hepatic clearance and enable animal imaging by four complementary techniques.

Diagnostic ImagingMaleMaterials scienceGadoliniumShell (structure)Mice Nudechemistry.chemical_elementHepatic clearanceNanotechnology02 engineering and technology010402 general chemistry[ CHIM ] Chemical Sciences01 natural sciencesCatalysisMiceAnimalsHumansNanotechnology[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Particle SizeComputingMilieux_MISCELLANEOUS010405 organic chemistryAnimal imagingGeneral MedicineGeneral Chemistry021001 nanoscience & nanotechnologyRats0104 chemical sciences3. Good healthMice Inbred C57BLCore (optical fiber)chemistry[ SDV.NEU ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]NanoparticlesFemale[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Gadolinium oxideParticle size0210 nano-technologyAngewandte Chemie International Edition
researchProduct

AGuIX® from bench to bedside-Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine.

2019

International audience; AGuIX® are sub-5 nm nanoparticles made of a polysiloxane matrix and gadolinium chelates. This nanoparticle has been recently accepted in clinical trials in association with radiotherapy. This review will summarize the principal preclinical results that have led to first in man administration. No evidence of toxicity has been observed during regulatory toxicity tests on two animal species (rodents and monkeys). Biodistributions on different animal models have shown passive uptake in tumours due to enhanced permeability and retention effect combined with renal elimination of the nanoparticles after intravenous administration. High radiosensitizing effect has been obser…

Radiation-Sensitizing AgentsGadoliniummedicine.medical_treatmentGadolinium02 engineering and technologyReview ArticlePharmacologyTheranostic NanomedicineMice0302 clinical medicineMelanomaBrain NeoplasmsMelanomaGeneral Medicine[CHIM.MATE]Chemical Sciences/Material chemistry[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences021001 nanoscience & nanotechnology3. Good health[SDV.SP] Life Sciences [q-bio]/Pharmaceutical sciencesNuclear Medicine & Medical ImagingRadiology Nuclear Medicine and imagingHead and Neck Neoplasms030220 oncology & carcinogenesisToxicity/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being[SDV.IB]Life Sciences [q-bio]/Bioengineering0210 nano-technologyClinical Scienceschemistry.chemical_element[SDV.CAN]Life Sciences [q-bio]/CancerEnhanced permeability and retention effect03 medical and health sciences/dk/atira/pure/subjectarea/asjc/2700/2741SDG 3 - Good Health and Well-being[SDV.CAN] Life Sciences [q-bio]/CancerIn vivo[CHIM.ANAL]Chemical Sciences/Analytical chemistrymedicineAnimalsHumansRadiology Nuclear Medicine and imaging[SDV.IB] Life Sciences [q-bio]/Bioengineeringbusiness.industryCancermedicine.diseaseRadiation therapyClinical trialchemistryNanoparticlesbusinessForecasting
researchProduct

AGuIX modifications for active tumor targeting and radiolabelling

2014

International audience

Radiotherapy[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/ImagingActive targeting[SDV]Life Sciences [q-bio][SDV.CAN]Life Sciences [q-bio]/Cancer[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciencesFunctionalisationImaging[SDV.SP] Life Sciences [q-bio]/Pharmaceutical sciences[SDV] Life Sciences [q-bio]Nanoparticle[SDV.IB.IMA] Life Sciences [q-bio]/Bioengineering/ImagingTheranostic[SDV.CAN] Life Sciences [q-bio]/Cancer[CHIM] Chemical Sciences[CHIM]Chemical SciencesComputingMilieux_MISCELLANEOUSMRICancer
researchProduct